Cargando…
Inhibition of Advanced Glycation and Absence of Galectin-3 Prevent Blood-Retinal Barrier Dysfunction during Short-Term Diabetes
Breakdown of the inner blood-retinal barrier (iBRB) occurs early in diabetes and is central to the development of sight-threatening diabetic macular edema (DME) as retinopathy progresses. In the current study, we examined how advanced glycation end products (AGEs) forming early in diabetes could mod...
Autores principales: | Canning, Paul, Glenn, Josephine V., Hsu, Daniel K., Liu, Fu-Tong, Gardiner, Tom A., Stitt, Alan W. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1880865/ https://www.ncbi.nlm.nih.gov/pubmed/17641742 http://dx.doi.org/10.1155/2007/51837 |
Ejemplares similares
-
Advanced glycation of the Arg-Gly-Asp (RGD) tripeptide motif modulates retinal microvascular endothelial cell dysfunction
por: McDonald, Denise M., et al.
Publicado: (2009) -
The bone marrow compartment is modified in the absence of galectin-3
por: Brand, C., et al.
Publicado: (2011) -
The Pleiotropic Effects of Simvastatin on Retinal Microvascular Endothelium Has Important Implications for Ischaemic Retinopathies
por: Medina, Reinhold J., et al.
Publicado: (2008) -
Role of the receptor for advanced glycation endproducts (RAGE) in retinal vasodegenerative pathology during diabetes in mice
por: McVicar, Carmel M., et al.
Publicado: (2015) -
Galectins in the Pathogenesis of Common Retinal Disease
por: Caridi, Bruna, et al.
Publicado: (2021)